MedAssets, Inc. (NASDAQ: MDAS), Humana (NYSE: HUM), Synchronoss Technologies, Inc. (NASDAQ: SNCR), Digital Realty Trust, Inc. (NYSE: DLR), Frontline Ltd. (NYSE: FRO), Ariad Pharmaceutical (NASDAQ: ARIA), Allegiant Travel (NASDAQ: ALGT), Capital Product Partners L.P. (NASDAQ: CPLP) and Gevo, Inc. (NASDAQ: GEVO) price targets adjusted by analysts.
MedAssets, Inc. (MDAS) had its price target lowered by UBS AG (NYSE:UBS) from $15.50 to $13.00. The have a “Neutral” rating on the company.
Humana (NYSE: HUM) had its price target raised by Barclays Capital from $85.00 to $90.00. They have an “Equal Weight” rating on the company.
Synchronoss Technologies, Inc. (SNCR) had its price target raised by Stifel Nicolaus from $38.00 to $44.00. They have a “Buy” rating on the company.
Digital Realty Trust, Inc. (DLR) had its price target lowered by Barclays Capital from $70.00 to $67.00. They have an “Overweight” rating on the company.
Frontline Ltd. (FRO) had its price target lowered by Deutsche Bank (NYSE:DB) from $22.00 to $16.00. They have a “Buy” rating on the company.
Ariad Pharmaceutical (ARIA) had its price target raised by Brean Murray from $11.00 to $15.00. They have a “Buy” rating on the company.
Allegiant Travel (ALGT) had its price target cut by Barclays Capital from $65.00 to $61.00. They have an “Overweight” rating on the company.
Capital Product Partners L.P. (CPLP) had its price target lowered by Deutsche Bank from $9.00 to $8.00. They have a “Hold” rating on the company.
Gevo, Inc. (GEVO) had its price target boosted by UBS AG from $21.00 to $23.00. They have a “Buy” rating on the company.
No comments:
Post a Comment